264 related articles for article (PubMed ID: 22708077)
21. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
Biswas M; Phan D; Watanabe M; Chan JY
J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
[TBL] [Abstract][Full Text] [Related]
22. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
[TBL] [Abstract][Full Text] [Related]
23. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
24. Regulating Fbw7 on the road to cancer.
Xu W; Taranets L; Popov N
Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
[TBL] [Abstract][Full Text] [Related]
25. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
Zhao D; Zheng HQ; Zhou Z; Chen C
Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
[TBL] [Abstract][Full Text] [Related]
26. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
[TBL] [Abstract][Full Text] [Related]
27. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin ligase Fbw7 restricts the replication of hepatitis C virus by targeting NS5B for ubiquitination and degradation.
Chen J; Wu X; Chen S; Chen S; Xiang N; Chen Y; Guo D
Biochem Biophys Res Commun; 2016 Feb; 470(3):697-703. PubMed ID: 26774344
[TBL] [Abstract][Full Text] [Related]
29. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
Busino L; Millman SE; Scotto L; Kyratsous CA; Basrur V; O'Connor O; Hoffmann A; Elenitoba-Johnson KS; Pagano M
Nat Cell Biol; 2012 Mar; 14(4):375-85. PubMed ID: 22388891
[TBL] [Abstract][Full Text] [Related]
30. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
31. Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.
Wang JY; Zhu B; Patterson LL; Rogan MR; Kibler CE; McBride JW
PLoS Pathog; 2020 Apr; 16(4):e1008541. PubMed ID: 32353058
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle-dependent ubiquitylation and destruction of NDE1 by CDK5-FBW7 regulates ciliary length.
Maskey D; Marlin MC; Kim S; Kim S; Ong EC; Li G; Tsiokas L
EMBO J; 2015 Oct; 34(19):2424-40. PubMed ID: 26206584
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.
Cassavaugh JM; Hale SA; Wellman TL; Howe AK; Wong C; Lounsbury KM
J Cell Biochem; 2011 Dec; 112(12):3882-90. PubMed ID: 21964756
[TBL] [Abstract][Full Text] [Related]
34. Aberrant regulation of FBW7 in cancer.
Wang L; Ye X; Liu Y; Wei W; Wang Z
Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
[TBL] [Abstract][Full Text] [Related]
35. The two faces of FBW7 in cancer drug resistance.
Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W
Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825
[TBL] [Abstract][Full Text] [Related]
36. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
Lau AW; Fukushima H; Wei W
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
[TBL] [Abstract][Full Text] [Related]
37. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.
Schülein C; Eilers M; Popov N
FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836
[TBL] [Abstract][Full Text] [Related]
38. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
[TBL] [Abstract][Full Text] [Related]
39. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance.
Cremona CA; Sancho R; Diefenbacher ME; Behrens A
Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034
[TBL] [Abstract][Full Text] [Related]
40. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
